Volume 24; Issue suppl 1

Annals of Oncology

Volume 24; Issue suppl 1
7

L07.03 * JAK2 INHIBITORS: PRESENT AND FUTURE

Vainchenker, W., Constantinescu, S.
Journal:
Annals of Oncology
Year:
2013
Language:
english
File:
PDF, 25 KB
english, 2013
10

Title Page

Journal:
Annals of Oncology
Year:
2013
File:
PDF, 120 KB
2013
11

L05.02 * TARGETING LACTATE METABOLISM IN CANCER

Critchlow, S. E.
Journal:
Annals of Oncology
Year:
2013
Language:
english
File:
PDF, 22 KB
english, 2013
12

L10.01 * NO ABSTRACT AVAILABLE

Journal:
Annals of Oncology
Year:
2013
File:
PDF, 15 KB
2013
13

L02.04 * AMP-224, A FUSION PROTEIN THAT TARGETS PD-1

Smothers, F., Hoos, A., Langermann, S., Marshall, S., May, R., Fleming, M.
Journal:
Annals of Oncology
Year:
2013
Language:
english
File:
PDF, 28 KB
english, 2013
16

L06.01 * GENE TRANSLOCATIONS AS TARGETS FOR TREATMENT

Janne, P. A.
Journal:
Annals of Oncology
Year:
2013
Language:
english
File:
PDF, 26 KB
english, 2013
21

L04.01 * TUMOR HETEROGENEITY: IS IT REALLY A PROBLEM?

Voest, E. E.
Journal:
Annals of Oncology
Year:
2013
File:
PDF, 26 KB
2013
27

L09.01 * NO ABSTRACT AVAILABLE

Journal:
Annals of Oncology
Year:
2013
File:
PDF, 15 KB
2013
29

P01.07 * EXPLOITATION OF MCTS /BSG AS THERAPEUTIC TARGETS IN LUNG CANCER

Granja, S.
Journal:
Annals of Oncology
Year:
2013
Language:
english
File:
PDF, 32 KB
english, 2013
35

L05.04 * MUTATION-SELECTIVE IDH INHIBITORS MEDIATE HISTONE AND DNA METHYLATION CHANGES

Agresta, S., Yen, K. E.
Journal:
Annals of Oncology
Year:
2013
Language:
english
File:
PDF, 24 KB
english, 2013
37

L10.02 * DESIGN AND CLINICAL DEVELOPMENT OF ANTIBODY DRUG CONJUGATES

Lutzker, S.
Journal:
Annals of Oncology
Year:
2013
Language:
english
File:
PDF, 22 KB
english, 2013
38

L10.03 * NO ABSTRACT AVAILABLE

Journal:
Annals of Oncology
Year:
2013
File:
PDF, 15 KB
2013
39

L12.01 * NO ABSTRACT AVAILABLE

Journal:
Annals of Oncology
Year:
2013
File:
PDF, 15 KB
2013
40

L12.02 * NO ABSTRACT AVAILABLE

Journal:
Annals of Oncology
Year:
2013
File:
PDF, 15 KB
2013
41

L03.02 * TARGETING THE P53 TUMOR SUPPRESSOR PATHWAY FOR IMPROVED CANCER THERAPY

Wiman, K. G.
Journal:
Annals of Oncology
Year:
2013
Language:
english
File:
PDF, 26 KB
english, 2013
44

L01.01 * NO ABSTRACT AVAILABLE

Journal:
Annals of Oncology
Year:
2013
File:
PDF, 15 KB
2013
46

L06.05 * HISTONE DEACETYLASE (HDAC) INHIBITION IN HEPATOCELLULAR CANCER

Chan, S. L., Yeo, W., Chan, A. T.
Journal:
Annals of Oncology
Year:
2013
Language:
english
File:
PDF, 25 KB
english, 2013
47

L07.02 * NO ABSTRACT AVAILABLE

Journal:
Annals of Oncology
Year:
2013
File:
PDF, 15 KB
2013
48

P01.02 * DOUBLE TARGETING FOR EWING SARCOMA CHEMOTHERAPY

Malvy, C. P., Vauthier, C., Bertrand, J. R., Ramon, A. L.
Journal:
Annals of Oncology
Year:
2013
Language:
english
File:
PDF, 41 KB
english, 2013
51

L04.01 * TUMOR HETEROGENEITY: IS IT REALLY A PROBLEM?

Voest, E. E.
Journal:
Annals of Oncology
Year:
2013
Language:
english
File:
PDF, 26 KB
english, 2013
52

L06.04 * ENDOTHELIAL CELL-DERIVED TARGETS THAT INDUCE THE CANCER STEM CELL PHENOTYPE

Ellis, L.
Journal:
Annals of Oncology
Year:
2013
Language:
english
File:
PDF, 27 KB
english, 2013
57

L06.02 * INHIBITOR OF ATR (ATAXIA TELANGIECTASIA AND RAD 3 RELATED) KINASE

Plummer, E. R.
Journal:
Annals of Oncology
Year:
2013
Language:
english
File:
PDF, 22 KB
english, 2013
59

L12.05 * NO ABSTRACT AVAILABLE

Journal:
Annals of Oncology
Year:
2013
File:
PDF, 15 KB
2013
60

L02.05 * NEW TOXICITIES OF IMMUNE CHECKPOINT MODULATORS

Hodi, F. S.
Journal:
Annals of Oncology
Year:
2013
Language:
english
File:
PDF, 22 KB
english, 2013
61

P01.01 * A NEW PARADIGM FOR CANCER THERAPY: A TARGETED SYSTEMIC PREVENTIVE/THERAPEUTIC APPROACH

Crawford, S.
Journal:
Annals of Oncology
Year:
2013
Language:
english
File:
PDF, 29 KB
english, 2013
71

L07.01 * HEMATOLOGY AND DRUG DEVELOPMENT IN THE 'TARGETED THERAPY' AREA

Ribrag, V.
Journal:
Annals of Oncology
Year:
2013
Language:
english
File:
PDF, 26 KB
english, 2013
77

Sponsors, supporters and exhibitors

Journal:
Annals of Oncology
Year:
2013
File:
PDF, 13 KB
2013
79

L11.03 * PRACTICAL APPLICATIONS OF AVATAR MOUSE MODELS IN CANCER DRUG DEVELOPMENT AND TREATMENT

Hidalgo, M.
Journal:
Annals of Oncology
Year:
2013
Language:
english
File:
PDF, 22 KB
english, 2013
82

L09.02 * TARGETING RAF KINASES IN BRAF AND KRAS MUTANT CANCERS

Luo, J.
Journal:
Annals of Oncology
Year:
2013
Language:
english
File:
PDF, 21 KB
english, 2013
85

P04.08 * PROGNOSTIC SIGNIFICANCE OF CYTOKERATIN MARKERS IN BREAST CANCER - A META ANALYSIS

Barak, V.
Journal:
Annals of Oncology
Year:
2013
Language:
english
File:
PDF, 29 KB
english, 2013
88

L04.03 * NEXT-GENERATION SEQUENCING AND PHASE I CLINICAL TRIALS IN CANCER

Janku, F.
Journal:
Annals of Oncology
Year:
2013
Language:
english
File:
PDF, 31 KB
english, 2013
89

L05.03 * THE MOLECULAR CONSEQUENCES OF INHIBITING FATTY ACID SYNTHASE IN CANCER CELLS

Wooster, R. F.
Journal:
Annals of Oncology
Year:
2013
Language:
english
File:
PDF, 23 KB
english, 2013
92

L02.02 * NO ABSTRACT AVAILABLE

Journal:
Annals of Oncology
Year:
2013
File:
PDF, 15 KB
2013
93

L09.04 * NO ABSTRACT AVAILABLE

Journal:
Annals of Oncology
Year:
2013
File:
PDF, 15 KB
2013
94

L10.04 * NO ABSTRACT AVAILABLE

Journal:
Annals of Oncology
Year:
2013
File:
PDF, 15 KB
2013
95

L12.04 * NO ABSTRACT AVAILABLE

Journal:
Annals of Oncology
Year:
2013
File:
PDF, 15 KB
2013
105

Drug index

Journal:
Annals of Oncology
Year:
2013
Language:
english
File:
PDF, 24 KB
english, 2013
106

Organizers

Journal:
Annals of Oncology
Year:
2013
Language:
english
File:
PDF, 21 KB
english, 2013
108

L01.02 * NO ABSTRACT AVAILABLE

Journal:
Annals of Oncology
Year:
2013
File:
PDF, 15 KB
2013
111

L11.01 * CHALLENGES TO PDTX MODELS IN DRUG DEVELOPMENT

Eckhardt, S. G.
Journal:
Annals of Oncology
Year:
2013
Language:
english
File:
PDF, 23 KB
english, 2013
114

L12.03 * NO ABSTRACT AVAILABLE

Journal:
Annals of Oncology
Year:
2013
File:
PDF, 15 KB
2013